Beyond The Numbers: 13 Analysts Discuss Johnson & Johnson Stock
Portfolio Pulse from Benzinga Insights
13 analysts have provided diverse opinions on Johnson & Johnson (JNJ) over the past quarter, with sentiments ranging from bullish to bearish. The average 12-month price target for JNJ has been raised to $191.0, indicating a 10.72% increase from the previous target of $172.50. Analysts' actions include maintaining, raising, and lowering ratings and price targets, reflecting their reaction to JNJ's market performance. JNJ's financial performance shows solid revenue growth, exceptional net margin, and strong ROE and ROA, with a conservative debt management approach.
February 28, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Johnson & Johnson's stock may see positive short-term movement due to the raised average 12-month price target and solid financial performance, despite mixed analyst sentiments.
The raised average 12-month price target reflects a positive outlook from analysts, despite a mix of opinions. JNJ's strong financial performance, including solid revenue growth, exceptional net margin, and strong ROE and ROA, supports a positive short-term impact on the stock price. The conservative debt management approach further solidifies its financial stability.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100